Med BioGene Inc. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
SG&A Expense
783.70
365.10
422.90
99.10
440.50
70.80
EBIT
783.70
365.10
422.90
35.90
440.50
70.80
Unusual Expense
-
-
54.70
65.30
-
-
Non Operating Income/Expense
1.40
43.20
0.00
0.60
0.40
-
Pretax Income
782.40
321.90
477.60
30.00
440.10
70.80
Consolidated Net Income
782.40
321.90
477.60
30.00
440.10
70.80
Net Income
782.40
321.90
477.60
30.00
440.10
70.80
Net Income After Extraordinaries
782.40
321.90
477.60
30.00
440.10
70.80
Net Income Available to Common
782.40
321.90
477.60
30.00
440.10
70.80
EPS (Basic)
0.10
0.04
0.06
0.00
0.05
0.01
Basic Shares Outstanding
7,902.80
8,094.80
8,620.00
8,721.50
8,757.80
8,757.80
EPS (Diluted)
0.10
0.04
0.06
0.00
0.05
0.01
Diluted Shares Outstanding
7,902.80
8,094.80
8,620.00
8,721.50
8,757.80
8,757.80
EBITDA
783.70
365.10
422.90
35.90
440.50
70.80
Other Operating Expense
-
-
-
63.20
-
-
About Med BioGene
View Profile
